Small Conductance Ca2+-Activated K+ Channels as Targets of CNS Drug Development

E-ISSN： 2212-5299|3|3|161-167

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.3, Iss.3, 2004-06, pp. : 161-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Large-Conductance Ca2+-Activated K+ Channels:Physiological Role and Pharmacology

Current Medicinal Chemistry, Vol. 10, Iss. 8, 2003-04 ,pp. : 649-661

Bentham Science Publishers

Access to resources Recommend Favorite

Large-Conductance, Ca2+-Activated K+ Channels: Function, Pharmacology and Drugs

Current Medicinal Chemistry, Vol. 9, Iss. 14, 2002-07 ,pp. : 1385-1395

Bentham Science Publishers

Access to resources Recommend Favorite

Small and intermediate conductance Ca²⁺-activated K⁺ channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavernosum

By Chen Mao Gorman Shelby Benson Bill Singh Kuljit Hieble J. Michel Martin Tate Simon Trezise Derek

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 6, 2004-06 ,pp. : 602-615

Springer Publishing Company

Access to resources Recommend Favorite

Hydralazine-induced vasodilation involves opening of high conductance Ca 2+ -activated K + channels

By Bang L. Nielsen-Kudsk J.E. Gruhn N. Trautner S. Theilgaard S.A. Olesen S.-P. Boesgaard S. Aldershvile J.

European Journal of Pharmacology, Vol. 361, Iss. 1, 1998-11 ,pp. : 43-49

Elsevier

Access to resources Recommend Favorite

Effects of large conductance Ca 2+ -activated K + channels on nitroglycerin-mediated vasorelaxation in humans

By Gruhn N. Boesgaard S. Eiberg J. Bang L. Thiis J. Schroeder T.V. Aldershvile J.

European Journal of Pharmacology, Vol. 446, Iss. 1, 2002-06 ,pp. : 145-150

Elsevier

Access to resources Recommend Favorite